Advanced CLD with S-CHOice®: higher productivity with transposase and ADCC with S-AfuCHO™
Enhancing productivity and antibody-dependent cellular cytotoxicity (ADCC) activity is key to developing high-performing antibody therapeutics. With the right approach and technology, there’s no need to compromise.
Our S-CHOice® and S-AfuCHO™ platforms are designed to optimize cell line performance, ensuring robust productivity while maintaining strong effector function.
Watch the webinar to learn how our advanced technologies can support your program.
Enhancing productivity and antibody-dependent cellular cytotoxicity (ADCC) activity is key to developing high-performing antibody therapeutics. With the right approach and technology, there’s no need to compromise.
Our S-CHOice® and S-AfuCHO™ platforms are designed to optimize cell line performance, ensuring robust productivity while maintaining strong effector function.
Watch the webinar to learn how our advanced technologies can support your program.
- CDO
- CGMP
- ADC
- Bio Campus
- IR
- CMO